{"id":50300,"date":"2022-10-31T22:02:42","date_gmt":"2022-10-31T21:02:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/"},"modified":"2022-10-31T22:02:42","modified_gmt":"2022-10-31T21:02:42","slug":"personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/","title":{"rendered":"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business"},"content":{"rendered":"
\n

MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the appointment of Christopher Hall as SVP and Head, Diagnostics Business. As part of the executive leadership team, Hall will drive the vision and strategy for commercializing Personalis\u2019 diagnostic product offerings.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe are excited to welcome Chris given his immense experience in successfully scaling diagnostics businesses,\u201d said John West, CEO of Personalis. \u201cHe is a great fit for Personalis as we expand into the clinical market. His track record is impressive \u2013 from CEO of a health technology start-up focused on multi-omics, to prior roles including leading Veracyte\u2019s commercial organization, launching its products, and growing the business to nearly $100 million in diagnostic revenue.\u201d\n<\/p>\n

\nHall brings over 20 years of experience in general management and product development within the diagnostics industry, most recently as CEO of Naring Health, Inc. Previously, he served as President, COO, and Chief Commercial Officer at Veracyte, Inc., where he led the company\u2019s commercial entry into endocrinology and pulmonology and scaled its operational groups. Hall also served as SVP and Chief Business Officer at Berkeley HeartLab, Inc. (part of Celera Corporation), where he helped a new product launch and restructured operations to improve profitability and streamline delivery of services.\n<\/p>\n

\nHall holds BA in political science and economics from DePauw University and an MBA from Harvard Business School.\n<\/p>\n

\nInducement Awards<\/b>\n<\/p>\n

\nEffective on October 31, 2022, the Compensation Committee of Personalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 275,000 shares of its common stock and restricted stock units (RSUs) covering an aggregate of 225,000 shares of its common stock to Hall under Personalis\u2019 2020 Inducement Plan. The inducement awards were granted to Hall as an inducement material to his entering into employment with Personalis, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The inducement stock options have an exercise price of $2.67 per share, which is equal to the closing price of Personalis\u2019 common stock on October 31, 2022, and will vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 1\/36th of the remaining shares vesting monthly thereafter, subject to continued service through each applicable vesting date. The RSUs will vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and an additional 25% of the shares vesting annually thereafter, subject to continued service through each applicable vesting date.\n<\/p>\n

\nAbout Personalis<\/b>\n<\/p>\n

\nPersonalis, Inc. is a leader in advanced cancer genomics, enabling the next generation of precision cancer therapies and diagnostics. The Personalis NeXT Platform<\/a>\u00ae is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers and clinicians with information on all of the approximately 20,000 human genes, together with the immune system, from a single sample. To enable cancer sequencing, Personalis’ Clinical Laboratory<\/a> was built with a focus on clinical accuracy, quality, big data, scale, and efficiency. The laboratory is GxP-aligned as well as Clinical Laboratory Improvement Amendments of 1988-certified and College of American Pathologists-accredited. For more information, visit the Personalis website<\/a> and News Center<\/a> follow Personalis on LinkedIn<\/a> and Twitter<\/a>.\n<\/p>\n

\nForward-Looking Statements<\/b>\n<\/p>\n

\nAll statements in this press release that are not historical are \u201cforward-looking statements\u201d within the meaning of U.S. securities laws, including statements relating to attributes or advantages of the NeXT Platform, Personalis\u2019 business opportunities, leadership, plans, or expectations, or other future events. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any anticipated results or expectations expressed or implied by such statements. Factors that could materially affect actual results can be found in Personalis\u2019 filings with the U.S. Securities and Exchange Commission, including Personalis\u2019 most recent reports on Forms 8-K, 10-K and 10-Q, and include those listed under the caption \u201cRisk Factors.\u201d Personalis disclaims any obligation to update such forward-looking statements.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations Contact for Personalis:<\/b>
Caroline Corner
\n
investors@personalis.com<\/a>
www.westwicke.com<\/a>
415-202-5678\n<\/p>\n

\nMedia Contact for Personalis:<\/b>
Jennifer Temple
\n
pr@personalis.com<\/a>
www.personalis.com<\/a>
650-752-1300\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the appointment of Christopher Hall as SVP and Head, Diagnostics Business. As part of the executive leadership team, Hall will drive the vision and strategy for commercializing Personalis\u2019 diagnostic product offerings. \u201cWe are excited to welcome Chris given his … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50300","6":"format-standard","7":"category-industry"},"yoast_head":"\nPersonalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the appointment of Christopher Hall as SVP and Head, Diagnostics Business. As part of the executive leadership team, Hall will drive the vision and strategy for commercializing Personalis\u2019 diagnostic product offerings. \u201cWe are excited to welcome Chris given his ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-31T21:02:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221031005594\/en\/839930\/21\/PersonalisLogo-RGB-no-tagline.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business\",\"datePublished\":\"2022-10-31T21:02:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/\"},\"wordCount\":687,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005594\\\/en\\\/839930\\\/21\\\/PersonalisLogo-RGB-no-tagline.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/\",\"name\":\"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005594\\\/en\\\/839930\\\/21\\\/PersonalisLogo-RGB-no-tagline.jpg\",\"datePublished\":\"2022-10-31T21:02:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005594\\\/en\\\/839930\\\/21\\\/PersonalisLogo-RGB-no-tagline.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005594\\\/en\\\/839930\\\/21\\\/PersonalisLogo-RGB-no-tagline.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/","og_locale":"en_US","og_type":"article","og_title":"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business - Pharma Trend","og_description":"MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the appointment of Christopher Hall as SVP and Head, Diagnostics Business. As part of the executive leadership team, Hall will drive the vision and strategy for commercializing Personalis\u2019 diagnostic product offerings. \u201cWe are excited to welcome Chris given his ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-31T21:02:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221031005594\/en\/839930\/21\/PersonalisLogo-RGB-no-tagline.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business","datePublished":"2022-10-31T21:02:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/"},"wordCount":687,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221031005594\/en\/839930\/21\/PersonalisLogo-RGB-no-tagline.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/","url":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/","name":"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221031005594\/en\/839930\/21\/PersonalisLogo-RGB-no-tagline.jpg","datePublished":"2022-10-31T21:02:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221031005594\/en\/839930\/21\/PersonalisLogo-RGB-no-tagline.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221031005594\/en\/839930\/21\/PersonalisLogo-RGB-no-tagline.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50300"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50300\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}